Stay updated on Quavonlimab Combo With Pembrolizumab in Advanced Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the Quavonlimab Combo With Pembrolizumab in Advanced Solid Tumors Clinical Trial page.

Latest updates to the Quavonlimab Combo With Pembrolizumab in Advanced Solid Tumors Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoNo Change Detected
- Check16 days agoChange DetectedThe page's revision tag was updated from v3.6.2 to v3.6.3, indicating a newer release of the page. This appears as a minor metadata update in the page footer.SummaryDifference0.0%

- Check23 days agoChange DetectedThe page history now shows Revision: v3.6.2, replacing the previous v3.6.0, indicating a version update rather than changes to study information.SummaryDifference0.0%

- Check37 days agoChange DetectedThe record now shows 'No longer looking for participants', indicating recruitment has ceased. The revision log has been updated to v3.6.0, replacing the previous v3.5.5 entry.SummaryDifference0.1%

- Check44 days agoChange DetectedThe revision history now shows Revision: v3.5.5, updating the page from v3.5.4. This change records a new version in the history without altering study data or page content.SummaryDifference0.0%

- Check66 days agoChange DetectedRevision label updated from v3.5.3 to v3.5.4 to reflect a new page build.SummaryDifference0.0%

- Check87 days agoChange DetectedThe page’s interface/version label was updated from one revision to the next (v3.5.2 → v3.5.3) without changing the underlying study record details.SummaryDifference0.0%

Stay in the know with updates to Quavonlimab Combo With Pembrolizumab in Advanced Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Quavonlimab Combo With Pembrolizumab in Advanced Solid Tumors Clinical Trial page.